Center for Molecular Medicine Cologne

Prof. Dr. Matthias Fischer - Curriculum Vitae

Education and Professional Career

since 2016: W2 Professorship, Head of the Department of Experimental Pediatric Oncology, University of Cologne
2015 - 2016: Research period at the Max-Planck-Institute for Metabolism Research, Cologne (Laboratory Prof. Dr. J. Brüning)
since 2014: Deputy head of the Department of Pediatric Oncology, University Hospital of Cologne
since 2013: Professor for Pediatrics, University of Cologne
since 2009: Consultant pediatric oncologist, University Hospital of Cologne
2007: Habilitation in Pediatrics, Medical Faculty, University of Cologne
2006: Board examination pediatrics
2005 - 2009: Resident physician, Department of Pediatric Oncology, University Hospital of Cologne
since 2001: Research group leader, Department of Pediatric Oncology, University of Cologne
2002: M.D. (Dr. med.), University of Cologne (Laboratory Prof. Dr. K. Rajewsky, Institute for Genetics)
1999 - 2005: Resident physician, Department of Pediatrics, University Hospital of Cologne
1999: Medical state examination, University of Cologne

Awards and Distinctions

2019: Fritz-Lampert Award 2019, TRANSAID – Stiftung für krebskranke Kinder
2018: Adalbert-Czerny Award 2018, German Society of Pediatrics and Adolescent Medicine (DGKJ)
since 2018: Elected member of the ANRA Steering Committee
since 2017: Steering committee member of the Phase I/II pediatric oncology clinical trial consortium Rhine/Ruhr
since 2017: Board of Directors of the international Massive Analysis and Quality Control (MAQC) Society
2016: Gerhard-Domagk Award for cancer research
since 2015: Board member of the Center for Integrated Oncology (CIO) Köln-Bonn
since 2014: Elected member of the Advances in Neuroblastoma Research Association (ANRA) Advisory Board Europe/Russia
since 2014: Member of the Individualized Therapy for Relapsed Malignancies in Childhood (INFORM) Steering Committee
since 2011: Member of the International Neuroblastoma Risk Group (INRG) and International Neuroblastoma Response Criteria (INPC) consortia
since 2009: Member of the GPOH Neuroblastoma Trial Committee


Link to PubMed